CDVCA has made a follow-on investment in MedRhythms, a digital therapeutics company that combines sensors, software, and music to address walking impairments caused by neurological conditions. Its innovative, evidence-based approach will significantly improve both mobility and quality of life for millions of people suffering from strokes or multiple sclerosis. MedRhythms is committed to promoting better healthcare solutions by advancing neurorehabilitation using its FDA-regulated prescription therapy technology. The company provides high-quality employment opportunities in a low-income community in Portland, Maine. CDVCA member fund Coastal Ventures 5 also invested.
